Copyright Reports & Markets. All rights reserved.

Global Congenital Heart Disease Market Size, Status and Forecast 2019-2025

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Key Market Segments
  • 1.3 Players Covered: Ranking by Congenital Heart Disease Revenue
  • 1.4 Market by Type
    • 1.4.1 Global Congenital Heart Disease Market Size Growth Rate by Type: 2020 VS 2026
    • 1.4.2 Medications
    • 1.4.3 Implantable heart devices
    • 1.4.4 Catheter procedures
    • 1.4.5 Open-heart surgery
    • 1.4.6 Heart transplant
  • 1.5 Market by Application
    • 1.5.1 Global Congenital Heart Disease Market Share by Application: 2020 VS 2026
    • 1.5.2 Hospitals and clinics
    • 1.5.3 Diagnostic centres
  • 1.6 Study Objectives
  • 1.7 Years Considered

2 Global Growth Trends

  • 2.1 Global Congenital Heart Disease Market Perspective (2015-2026)
  • 2.2 Global Congenital Heart Disease Growth Trends by Regions
    • 2.2.1 Congenital Heart Disease Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 Congenital Heart Disease Historic Market Share by Regions (2015-2020)
    • 2.2.3 Congenital Heart Disease Forecasted Market Size by Regions (2021-2026)
  • 2.3 Industry Trends and Growth Strategy
    • 2.3.1 Market Top Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Challenges
    • 2.3.4 Porter’s Five Forces Analysis
    • 2.3.5 Congenital Heart Disease Market Growth Strategy
    • 2.3.6 Primary Interviews with Key Congenital Heart Disease Players (Opinion Leaders)

3 Competition Landscape by Key Players

  • 3.1 Global Top Congenital Heart Disease Players by Market Size
    • 3.1.1 Global Top Congenital Heart Disease Players by Revenue (2015-2020)
    • 3.1.2 Global Congenital Heart Disease Revenue Market Share by Players (2015-2020)
    • 3.1.3 Global Congenital Heart Disease Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.2 Global Congenital Heart Disease Market Concentration Ratio
    • 3.2.1 Global Congenital Heart Disease Market Concentration Ratio (CR5 and HHI)
    • 3.2.2 Global Top 10 and Top 5 Companies by Congenital Heart Disease Revenue in 2019
  • 3.3 Congenital Heart Disease Key Players Head office and Area Served
  • 3.4 Key Players Congenital Heart Disease Product Solution and Service
  • 3.5 Date of Enter into Congenital Heart Disease Market
  • 3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

  • 4.1 Global Congenital Heart Disease Historic Market Size by Type (2015-2020)
  • 4.2 Global Congenital Heart Disease Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)

  • 5.1 Global Congenital Heart Disease Market Size by Application (2015-2020)
  • 5.2 Global Congenital Heart Disease Forecasted Market Size by Application (2021-2026)

6 North America

  • 6.1 North America Congenital Heart Disease Market Size (2015-2020)
  • 6.2 Congenital Heart Disease Key Players in North America (2019-2020)
  • 6.3 North America Congenital Heart Disease Market Size by Type (2015-2020)
  • 6.4 North America Congenital Heart Disease Market Size by Application (2015-2020)

7 Europe

  • 7.1 Europe Congenital Heart Disease Market Size (2015-2020)
  • 7.2 Congenital Heart Disease Key Players in Europe (2019-2020)
  • 7.3 Europe Congenital Heart Disease Market Size by Type (2015-2020)
  • 7.4 Europe Congenital Heart Disease Market Size by Application (2015-2020)

8 China

  • 8.1 China Congenital Heart Disease Market Size (2015-2020)
  • 8.2 Congenital Heart Disease Key Players in China (2019-2020)
  • 8.3 China Congenital Heart Disease Market Size by Type (2015-2020)
  • 8.4 China Congenital Heart Disease Market Size by Application (2015-2020)

9 Japan

  • 9.1 Japan Congenital Heart Disease Market Size (2015-2020)
  • 9.2 Congenital Heart Disease Key Players in Japan (2019-2020)
  • 9.3 Japan Congenital Heart Disease Market Size by Type (2015-2020)
  • 9.4 Japan Congenital Heart Disease Market Size by Application (2015-2020)

10 Southeast Asia

  • 10.1 Southeast Asia Congenital Heart Disease Market Size (2015-2020)
  • 10.2 Congenital Heart Disease Key Players in Southeast Asia (2019-2020)
  • 10.3 Southeast Asia Congenital Heart Disease Market Size by Type (2015-2020)
  • 10.4 Southeast Asia Congenital Heart Disease Market Size by Application (2015-2020)

11 India

  • 11.1 India Congenital Heart Disease Market Size (2015-2020)
  • 11.2 Congenital Heart Disease Key Players in India (2019-2020)
  • 11.3 India Congenital Heart Disease Market Size by Type (2015-2020)
  • 11.4 India Congenital Heart Disease Market Size by Application (2015-2020)

12 Central & South America

  • 12.1 Central & South America Congenital Heart Disease Market Size (2015-2020)
  • 12.2 Congenital Heart Disease Key Players in Central & South America (2019-2020)
  • 12.3 Central & South America Congenital Heart Disease Market Size by Type (2015-2020)
  • 12.4 Central & South America Congenital Heart Disease Market Size by Application (2015-2020)

13 Key Players Profiles

  • 13.1 Abbott Diagnostics
    • 13.1.1 Abbott Diagnostics Company Details
    • 13.1.2 Abbott Diagnostics Business Overview
    • 13.1.3 Abbott Diagnostics Congenital Heart Disease Introduction
    • 13.1.4 Abbott Diagnostics Revenue in Congenital Heart Disease Business (2015-2020))
    • 13.1.5 Abbott Diagnostics Recent Development
  • 13.2 Array BioPharma
    • 13.2.1 Array BioPharma Company Details
    • 13.2.2 Array BioPharma Business Overview
    • 13.2.3 Array BioPharma Congenital Heart Disease Introduction
    • 13.2.4 Array BioPharma Revenue in Congenital Heart Disease Business (2015-2020)
    • 13.2.5 Array BioPharma Recent Development
  • 13.3 AstraZeneca
    • 13.3.1 AstraZeneca Company Details
    • 13.3.2 AstraZeneca Business Overview
    • 13.3.3 AstraZeneca Congenital Heart Disease Introduction
    • 13.3.4 AstraZeneca Revenue in Congenital Heart Disease Business (2015-2020)
    • 13.3.5 AstraZeneca Recent Development
  • 13.4 Becton Dickinson
    • 13.4.1 Becton Dickinson Company Details
    • 13.4.2 Becton Dickinson Business Overview
    • 13.4.3 Becton Dickinson Congenital Heart Disease Introduction
    • 13.4.4 Becton Dickinson Revenue in Congenital Heart Disease Business (2015-2020)
    • 13.4.5 Becton Dickinson Recent Development
  • 13.5 BG Medicine
    • 13.5.1 BG Medicine Company Details
    • 13.5.2 BG Medicine Business Overview
    • 13.5.3 BG Medicine Congenital Heart Disease Introduction
    • 13.5.4 BG Medicine Revenue in Congenital Heart Disease Business (2015-2020)
    • 13.5.5 BG Medicine Recent Development
  • 13.6 Bio-Rad
    • 13.6.1 Bio-Rad Company Details
    • 13.6.2 Bio-Rad Business Overview
    • 13.6.3 Bio-Rad Congenital Heart Disease Introduction
    • 13.6.4 Bio-Rad Revenue in Congenital Heart Disease Business (2015-2020)
    • 13.6.5 Bio-Rad Recent Development
  • 13.7 Boston Scientific
    • 13.7.1 Boston Scientific Company Details
    • 13.7.2 Boston Scientific Business Overview
    • 13.7.3 Boston Scientific Congenital Heart Disease Introduction
    • 13.7.4 Boston Scientific Revenue in Congenital Heart Disease Business (2015-2020)
    • 13.7.5 Boston Scientific Recent Development
  • 13.8 Covance
    • 13.8.1 Covance Company Details
    • 13.8.2 Covance Business Overview
    • 13.8.3 Covance Congenital Heart Disease Introduction
    • 13.8.4 Covance Revenue in Congenital Heart Disease Business (2015-2020)
    • 13.8.5 Covance Recent Development
  • 13.9 Critical Diagnostics
    • 13.9.1 Critical Diagnostics Company Details
    • 13.9.2 Critical Diagnostics Business Overview
    • 13.9.3 Critical Diagnostics Congenital Heart Disease Introduction
    • 13.9.4 Critical Diagnostics Revenue in Congenital Heart Disease Business (2015-2020)
    • 13.9.5 Critical Diagnostics Recent Development
  • 13.10 Roche
    • 13.10.1 Roche Company Details
    • 13.10.2 Roche Business Overview
    • 13.10.3 Roche Congenital Heart Disease Introduction
    • 13.10.4 Roche Revenue in Congenital Heart Disease Business (2015-2020)
    • 13.10.5 Roche Recent Development
  • 13.11 GSK
    • 10.11.1 GSK Company Details
    • 10.11.2 GSK Business Overview
    • 10.11.3 GSK Congenital Heart Disease Introduction
    • 10.11.4 GSK Revenue in Congenital Heart Disease Business (2015-2020)
    • 10.11.5 GSK Recent Development
  • 13.12 Janssen Pharmaceuticals
    • 10.12.1 Janssen Pharmaceuticals Company Details
    • 10.12.2 Janssen Pharmaceuticals Business Overview
    • 10.12.3 Janssen Pharmaceuticals Congenital Heart Disease Introduction
    • 10.12.4 Janssen Pharmaceuticals Revenue in Congenital Heart Disease Business (2015-2020)
    • 10.12.5 Janssen Pharmaceuticals Recent Development
  • 13.13 Medtronic
    • 10.13.1 Medtronic Company Details
    • 10.13.2 Medtronic Business Overview
    • 10.13.3 Medtronic Congenital Heart Disease Introduction
    • 10.13.4 Medtronic Revenue in Congenital Heart Disease Business (2015-2020)
    • 10.13.5 Medtronic Recent Development
  • 13.14 Merck
    • 10.14.1 Merck Company Details
    • 10.14.2 Merck Business Overview
    • 10.14.3 Merck Congenital Heart Disease Introduction
    • 10.14.4 Merck Revenue in Congenital Heart Disease Business (2015-2020)
    • 10.14.5 Merck Recent Development
  • 13.15 Mylan
    • 10.15.1 Mylan Company Details
    • 10.15.2 Mylan Business Overview
    • 10.15.3 Mylan Congenital Heart Disease Introduction
    • 10.15.4 Mylan Revenue in Congenital Heart Disease Business (2015-2020)
    • 10.15.5 Mylan Recent Development

14 Analyst's Viewpoints/Conclusions

    15 Appendix

    • 15.1 Research Methodology
      • 15.1.1 Methodology/Research Approach
      • 15.1.2 Data Source
    • 15.2 Disclaimer

    Congenital Heart Disease market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Congenital Heart Disease market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

    The key players covered in this study
    Abbott Diagnostics
    Array BioPharma
    AstraZeneca
    Becton Dickinson
    BG Medicine
    Bio-Rad
    Boston Scientific
    Covance
    Critical Diagnostics
    Roche
    GSK
    Janssen Pharmaceuticals
    Medtronic
    Merck
    Mylan

    Market segment by Type, the product can be split into
    Medications
    Implantable heart devices
    Catheter procedures
    Open-heart surgery
    Heart transplant
    Market segment by Application, split into
    Hospitals and clinics
    Diagnostic centres

    Market segment by Regions/Countries, this report covers
    North America
    Europe
    China
    Japan
    Southeast Asia
    India
    Central & South America

    Buy now